Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody Response

The CYD-TDV vaccine is licensed in multiple endemic countries based on vaccine efficacy (VE) against symptomatic, virologically confirmed dengue demonstrated in two phase 3 trials (CYD14, 2- to 14-year-olds, Asia; CYD15, 9- to 16-year-olds, Latin America). 50% plaque reduction neutralization test (P...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Trop Med Hyg
Main Authors: Gilbert, Peter B., Huang, Ying, Juraska, Michal, Moodie, Zoe, Fong, Youyi, Luedtke, Alexander, Zhuang, Yingying, Shao, Jason, Carpp, Lindsay N., Jackson, Nicholas, Chambonneau, Laurent, Bouckenooghe, Alain, Zambrano, Betzana, Frago, Carina, Pallardy, Sophie, Noriega, Fernando
Formato: Artigo
Idioma:Inglês
Publicado: The American Society of Tropical Medicine and Hygiene 2019
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6609170/
https://ncbi.nlm.nih.gov/pubmed/31115304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.18-0534
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares